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Extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae are well-known pathogens, 
increasingly reported in the environment. This fact represents a human health concern since third-generation 
cephalosporins are frontline antibiotics used to treat infections caused by this species. A major question is 
whether environmental ESBL-producing K. pneumoniae can infect humans. To address this question, this 
study compared clinical and environmental K. pneumoniae strains regarding genetic and phenotypic traits 
and assessed their potential infectious capacity. Therefore, 59 isolates (25 environmental and 34 clinical) of 
cefotaxime-resistant K. pneumoniae were characterized based on antibiotic resistance phenotype, plasmids 
content, and horizontal gene transfer capacity. A subset of these isolates was tested for infection capacity in 
Galleria mellonella (23 environmental and 24 clinical) and for whole genome sequencing (7 environmental 
and 11 clinical). Most environmental (80%, 20/25) and clinical isolates (94%, 32/34) were multidrug resistant. 
Environmental isolates presented mostly 2 plasmids (48%, 12/25) while clinical isolates presented 1 or 2 
plasmids (41%, 14/34 each), however bacterial conjugation was more frequent among clinical (76%, 26/34) 
than environmental isolates (40%, 10/25). G. mellonella health index was lower after infection with clinical 
(most of the infected isolates scored 1) than with environmental isolates (most of the infected isolates scored 
6). A screening of the whole genome sequences, made in parallel with data available in public databases (in 
total 73 environmental and 78 clinical), targeting 6 groups of genes related to antibiotic and metal resistance, 
virulence, efflux systems, oxidative stress and quorum sensing, evidenced the existence of 1383 gene 
variants. A total of 438 genes out of the 1383 were common to all isolates, while 460 and 485 genes were 
found exclusively in environmental and in clinical isolates, respectively. A screening of the whole genome-
deduced amino acid sequences demonstrated a common putative proteome, related with all functional 
categories, in environmental and clinical isolates (n=2715), although the number of exclusive amino acid 
sequences was higher for clinical isolates (n=577 in clinical vs. n=205 in environmental). These results 
suggest the adaptation of K. pneumoniae to environmental or clinical niches, although highlight that putative 
clinically relevant traits may persist in bacteria thriving in the environment. 
